Skip to main content
CANC logo

Tema Oncology ETF

CANCNASDAQTemaEquity

$40.26Today:−$0.80 (−1.95%)1Y +19.88%

As of Nov 16, 2026 close

Assets (AUM)
$206.87M
Expense ratio
0.75%
Dividend yield
0.05%
Holdings
58
52-week range
$33.25$47.00
Volume (live)
-
Avg. volume (3M)
18.71K

CANC ETF Holdings: Tema Oncology ETF

The largest positions with their portfolio weights, plus sector breakdown and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.

Total Holdings
58
Updated Nov 14, 2026
Top 10 Holdings
44.9%
Share of fund assets
Assets (AUM)
$206.87M
Total fund assets
Expense Ratio
0.75%
Annual management fee

Portfolio Allocations

Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.

Loading chart...

Top 25 of 58 CANC Holdings by Portfolio Weight

Holdings data last updated Nov 14, 2026. Ticker, name, asset type and portfolio weight for each position. Fund disclosures available to us list the largest 25 positions.

Scroll to see more
CANC ETF holdings table showing rank, ticker symbol, company name, asset type, and portfolio weight percentage, sorted by portfolio weight, last updated Nov 14, 2026.
#SymbolNameTypeWeight
1
GMAB logo
GMAB
Genmab A/SStock5.92%
2
RVMD logo
RVMD
Revolution Medicines, Inc.Stock5.43%
3
LLY logo
LLY
Eli Lilly and CompanyStock5.43%
4
MRK logo
MRK
Merck & Co., Inc.Stock4.86%
5
COGT logo
COGT
Cogent Biosciences, Inc.Stock4.30%
6
ONC logo
ONC
BeOne Medicines AGStock4.24%
7
SWX:NOVN
Novartis AGStock4.06%
8
ABBV logo
ABBV
AbbVie Inc.Stock3.76%
9
EXEL logo
EXEL
Exelixis, Inc.Stock3.72%
10
BBIO logo
BBIO
BridgeBio Pharma, Inc.Stock3.16%
11
OTC:RHHBY
Roche Holding AGStock3.13%
12
HALO logo
HALO
Halozyme Therapeutics, Inc.Stock2.97%
13
ELVN logo
ELVN
Enliven Therapeutics, Inc.Stock2.81%
14
CGON logo
CGON
CG Oncology, Inc.Stock2.73%
15
BMY logo
BMY
Bristol-Myers Squibb CompanyStock2.68%
16
RLAY logo
RLAY
Relay Therapeutics, Inc.Stock2.37%
17
LON:AZN
AstraZeneca PLCStock2.33%
18
JNJ logo
JNJ
Johnson & JohnsonStock2.30%
19
IDYA logo
IDYA
IDEAYA Biosciences, Inc.Stock2.26%
20
ERAS logo
ERAS
Erasca, Inc.Stock2.15%
21
IMNM logo
IMNM
Immunome, Inc.Stock2.12%
22
AMGN logo
AMGN
Amgen Inc.Stock1.96%
23
ZLAB logo
ZLAB
Zai Lab LimitedStock1.92%
24
LEGN logo
LEGN
Legend Biotech CorporationStock1.88%
25
IOVA logo
IOVA
Iovance Biotherapeutics, Inc.Stock1.74%

Source: Fund holdings disclosures. Last updated Nov 14, 2026. Data sources and methodology

Frequently Asked Questions About Tema Oncology ETF Holdings

What are the top holdings in CANC?

In holdings data last updated Nov 14, 2026, CANC's largest holdings are Genmab A/S (GMAB) at 5.92%, Revolution Medicines, Inc. (RVMD) at 5.43%, Eli Lilly and Company (LLY) at 5.43%, Merck & Co., Inc. (MRK) at 4.86% and Cogent Biosciences, Inc. (COGT) at 4.30%. Together these 5 positions make up 25.9% of the fund. CANC holds 58 securities in all; the holdings data lists the top 25 by weight.

How concentrated is CANC's portfolio?

In holdings data last updated Nov 14, 2026, the 10 largest of CANC's 58 positions make up 44.9% of assets. The largest single position is Genmab A/S (GMAB) at 5.92%. The top 25 listed positions add up to 80.2%, so the remaining 33 holdings share 19.8%. Its largest sector, Healthcare, is 100.0% of the portfolio.

What is CANC's sector allocation?

In holdings data last updated Nov 14, 2026, CANC's largest sector weights are Healthcare (100.0%), together 100.0% of the portfolio. It has exposure to 1 sector in total.

What countries does CANC invest in?

In holdings data last updated Nov 14, 2026, 76.6% of CANC's portfolio is invested in the United States, followed by Switzerland (11.4%), Denmark (5.9%) and the United Kingdom (3.2%). CANC has exposure to 7 countries in total. By asset type the fund is 98.9% stocks and 1.1% cash.